Core Viewpoint - The company, Shibu Testing (301228.SZ), reported a decline in revenue and continued net losses for the first half of 2025, indicating ongoing financial challenges [1][2]. Financial Performance - For the first half of 2025, the company achieved operating revenue of 167.20 million yuan, a year-on-year decrease of 15.97% compared to 198.98 million yuan in the same period last year [2]. - The net profit attributable to shareholders was -26.98 million yuan, slightly worsening from -26.33 million yuan in the previous year, reflecting a decrease of 2.45% [2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -28.66 million yuan, compared to -27.35 million yuan in the same period last year, marking a decline of 4.79% [2]. - The net cash flow from operating activities was -14.55 million yuan, a significant drop from -9.99 million yuan in the previous year, representing a decrease of 45.65% [2]. Historical Financial Data - From 2022 to 2024, the company's operating revenue was 351.47 million yuan, 373.83 million yuan, and 442.11 million yuan, respectively, showing a growth trend [3]. - The net profit attributable to shareholders for the same years was -17.96 million yuan, -93.54 million yuan, and -65.79 million yuan, indicating a gradual improvement in losses [3]. - The net profit after deducting non-recurring gains and losses for the same years was -31.35 million yuan, -97.71 million yuan, and -67.02 million yuan, also showing a trend of reduced losses [3]. - The net cash flow from operating activities for these years was 782.06 thousand yuan, -1.36 million yuan, and 24.35 million yuan, indicating a significant recovery in cash flow in 2024 [3]. Initial Public Offering (IPO) Details - Shibu Testing was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on January 28, 2022, with a public offering of 30 million shares, accounting for 25% of the total share capital post-issue, at a price of 20.08 yuan per share [4]. - The total amount raised from the IPO was 602.40 million yuan, with a net amount of 526.33 million yuan after deducting issuance costs, exceeding the original plan by 124.23 million yuan [4]. - The funds raised are intended for the construction of a new laboratory project, the establishment of a research and development information center, and to supplement working capital [4].